Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...
AI coding agent Cursor has launched Origin, a git based code hosting platform embedded inside its AI-powered editor, ...
A 41-day experiment reveals how JavaScript-only navigation limits AI crawler discovery and why fixing it later can be harder.
Find out why the results may temper claims that recursive self-improvement is on the horizon. —Michelle Kim This summer has ...
Find out the direct holders, institutional holders and mutual fund holders for Recursion Pharmaceuticals, Inc. (RXRX).
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results